News
Video
Podcasts
Journals
Conferences
Events
Resources
CE
About AJMC
Subscribe

Spotlight -

Free In-Person Regional Events Focused on Oncology and Population Health

|Articles|December 2, 2022

AJMC® in the Press, December 2, 2022

Author(s)AJMC Staff

Coverage of our peer-reviewed research and news reporting in the health care and mainstream press.

A piece by LGBTQ Nation cited an article published on AJMC.com, the website of The American Journal of Managed Care^®. The article, “FDA's Revised Blood Donation Guidance for Gay Men Still Courts Controversy,” covered an announcement by the FDA on the easing of its restrictions on gay men being allowed to donate blood amid the COVID-19 pandemic.

Newsletter

Stay ahead of policy, cost, and value—subscribe to AJMC for expert insights at the intersection of clinical care and health economics.

Related Content

Researchers identified 3 overarching themes: a prolonged journey with symptoms, multiple trials of therapy with inadequate control, and diverse experiences with AIT. | Image credit: Volha Zaitsava - stock.adobe.com

Highlighting Gaps in Allergic Rhinitis Care, Allergen Immunotherapy Access

January 23rd 2026

The findings reinforce the need for earlier recognition of scarring alopecias—particularly CCCA—and improved education for clinicians. | Image Credit: cattyphoto - stock.adobe.com

CCCA Associated With Longer Time to Diagnosis Vs Other Scarring Alopecias

January 23rd 2026

Center on Health Equity and Access

Health Equity & Access Weekly Roundup: January 23, 2026

ByGiuliana Grossi

January 23rd 2026

First-line anlotinib plus chemotherapy demonstrates favorable efficacy and manageable toxicity in advanced STS. | Image credit: @Aidman-Adobestock.jpeg

Anlotinib Plus Chemotherapy Shows Promising Results in Advanced Soft Tissue Sarcoma

BySabrina McCrear

January 23rd 2026

Homelessness | Image credit: 2B - stock.adobe.com

Federal Prevention Solutions to Homelessness Improved Health Outcomes in VA Patients

ByJulia Bonavitacola

January 23rd 2026

Latest CME

Innovations in Medicine: 2024 Lineup of New and Approved Specialty Drugs

Innovations in Medicine: 2024 Lineup of New and Approved Specialty Drugs

2.0 Credits / General Pharmacy

Trending on AJMC

Health Insurance CEOs Questioned by House Committee About Rising Costs in Health Care

Semaglutide Shows Promise for Steatohepatitis Resolution in MASH

Advancing Biomarker Testing Across GU, Lung, and Myeloma Care

Smart Speaker Improves Mental Health, A1C in Older Adults With Diabetes

Federal Prevention Solutions to Homelessness Improved Health Outcomes in VA Patients

259 Prospect Plains Rd, Bldg H
Cranbury, NJ 08512

© 2025 MJH Life Sciences^®

All rights reserved.